Creation of Porous Fibers for Adsorbing Pathogenic Substances in Intractable Diseases
NQ Score
56/100
AI Summary (NQ-processed)
Toray Industries has developed a technology to control the pore size of PMMA porous fibers up to 1,000nm. This allows for the selective removal of large pathogenic substances like autoantibodies and exosomes, offering new blood purification treatment options.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: What is the key advantage of this technology?
- A: It allows for real-time control of PMMA porous fiber pore sizes up to approximately 1,000nm, which is 50 times larger than conventional capabilities, while maintaining structural strength.